PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,776,000 | -35.8% | 250,000 | -17.1% | 0.04% | -65.6% |
Q3 2021 | $8,991,000 | -82.4% | 301,714 | -79.8% | 0.13% | -60.4% |
Q2 2021 | $51,004,000 | +107.7% | 1,493,114 | +100.0% | 0.33% | +6.4% |
Q1 2021 | $24,554,000 | -54.9% | 746,557 | -15.7% | 0.31% | -46.8% |
Q4 2020 | $54,471,000 | +153.4% | 885,556 | +46.2% | 0.58% | +86.3% |
Q3 2020 | $21,497,000 | – | 605,556 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $19,217,000 | 59.24% |
Euclidean Capital LLC | 2,336,909 | $27,809,000 | 25.82% |
OUP Management Co., LLC | 989,232 | $11,772,000 | 18.33% |
Nextech Invest Ltd. | 1,385,807 | $16,491,000 | 5.33% |
Boxer Capital, LLC | 3,163,795 | $37,649,000 | 2.12% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $6,549,000 | 1.64% |
Orbimed Advisors | 6,563,077 | $78,101,000 | 1.45% |
RTW INVESTMENTS, LP | 4,356,920 | $51,847,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 154,500 | $1,839,000 | 0.79% |
Monarch Partners Asset Management LLC | 210,370 | $2,503,000 | 0.75% |